Finding Links and Missing Genes
News Oct 06, 2015
Missing a gene may be less problematic than you’d think. This is one of the conclusions that emerge from the most extensive catalogue of structural variations - changes in large sections of a person’s DNA sequence - to date.
Created by researchers at the European Molecular Biology Laboratory (EMBL), the University of Washington, and collaborators, this reference catalogue shows how these large-scale genetic alterations vary in populations across the globe, and will help guide future studies of genetics, evolution and disease. The work, carried out with the 1000 Genomes Project, is published in Nature, alongside a paper on the project’s final outcomes.
“When we analyzed the genomes of 2500 people, we were surprised to see over 200 genes that are missing entirely in some people,” says Jan Korbel, who led the work at EMBL in Heidelberg, Germany.
“Genome sequencing is beginning to be used for diagnostic purposes, and when doctors see that a piece of the genome is missing in a patient, there’s a temptation to tie that to a diagnosis,” says Evan Eichler, who led the work at the University of Washington. “We can now let clinicians know that there are certain genes that really should not be used to try to explain diseases in this way.”
Many studies have implicated broadly-defined regions of the genome in common diseases. Interestingly, the large-scale changes catalogued by Korbel, Eichler and colleagues frequently occur in such disease-linked regions, implying that these structural variations are probably common risk factors for disease.
“Our work reveals that structural variations are often likely to have functional consequences,” says Oliver Stegle, whose team at EMBL’s European Bioinformatics Institute (EMBL-EBI) took part in the study. “So we can now advise on what researchers should be looking for when they’re trying to understand the genetic causes of a certain condition.”
In keeping with existing knowledge about genetic diversity, the team found that the structural variations present in people’s genomes depend on where in the world they come from. In European and Asian populations, structural variations made up a greater proportion of changes to the genome than in African populations, while African genomes harboured a much greater diversity overall.
The scientists also showed that structural variations often have greater effects than changes in single letters of the genome (SNPs). And thanks to technological developments, they were able to catalogue new types of structural variation that previous studies had been missing.
“We were astonished to find variations which cannot be accounted for by the processes that researchers believed usually alter the genome,” says Korbel, “it will be interesting to find out how these structural variations do arise.”
The work was part of the 1000 Genomes Project, which examined genetic variation in over 2500 human genomes, with all data made available online immediately as it emerged. Thanks to this public repository, managed at EMBL-EBI, other scientists have already begun to access and make use of the data.
“We’re extremely grateful to everyone who donated their DNA to the project and made it available to use openly for research that can enable future biomedical advances,” says Paul Flicek, who is in charge of the public repository of the data at EMBL-EBI. “Their generosity has not only enabled this project, but will continue to bear fruits in years to come, as many studies will make use of the data.”
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018